X
Donate
Research and discoveries
Study and careers
Industry partnerships
About us
Support us
Research and discoveries
Find a researcher
ICR divisions
Centres and strategic collaborations
Our research
Our facilities and technology
Research by cancer type
Cancer discovery news
Cancer blogs
ICR divisions
Breast Cancer Research
Cancer Biology
Cancer Therapeutics
Cell and Molecular Biology
Clinical Studies
Genetics and Epidemiology
Radiotherapy and Imaging
Structural Biology
Our research
ICR research themes
Our research excellence
Academic excellence
Animal research
Data Science
Drug and therapeutic discovery
Our facilities and technology
Breast Cancer Now Nina Barough Pathology Core Facility
Baculovirus Facility
Light Microscopy Facility
Electron Microscopy Facility
Flow Cytometry Facility
Mechanical Workshop and 3D Printing
Proteomics Core Facility
Scientific Computing Service
Genomics Facility
X-ray Crystallography Facility
Chelsea Biophysics Facility
Correlative Light and Electron Microscopy (CLEM) Lab
Antibody Facility
Research by cancer type
Bladder cancer
Blood cancers
Bone cancer
Bowel cancer
Brain cancer
Breast cancer
Cervical cancer
Childhood cancers
Gastrointestinal cancers
Head and neck cancer
Kidney cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
Cancer blogs
Research blogs
The Darwin Cancer Blog
Study and careers
PhDs for science graduates
Opportunities for clinicians
Student life and support
Undergraduate Summer Scholarship Scheme
Support moving to the UK
Careers at the ICR
Working life and benefits
PhDs for science graduates
Our PhD projects
Our PhD application process
PhD FAQs and funding
Contact student admissions
PhDs and training news
Opportunities for clinicians
MSc in Oncology
PhD and MD(Res) for clinicians
NIHR academic training
Radiotherapy and imaging training courses
Opportunities for postdoctoral clinical fellows
Student life and support
Tuition fees
Accommodation support
Social life and welfare
Academic and career support
Student resources
Student stories
Alumni stories
Undergraduate Summer Scholarship Scheme
How to apply
FAQs
Research groups
Careers at the ICR
Postdocs
Research scientists and scientific support
Group leaders
Clinicians
Professional Service roles
Contact our career faculty
Apprenticeships
Working life and benefits
Staff benefits
World-leading working facilities
Equality and social groups
Career development
Employee stories
Industry partnerships
Partnership opportunities
Consultancy in oncology
Why partner with us
Our therapeutic pipeline
London Cancer Hub
Contact our partner team
Why partner with us
Our partnership philosophy
The Innovation Gateway
Entrepreneurs-in-residence
Spin-out companies
Enterprise events
Our treatment and technology successes
About us
Our history
Leadership and governance
Our strategy
ICR and The Royal Marsden
Our achievements
Patient stories
Public engagement and schools outreach
Funding and spending
Corporate reports and policies
ICR news
Contact us
Leadership and governance
Our leadership team
Executive board
Board of trustees
Corporate governance
ICR committees
Our strategy
Strategic partners
Our values
Equality and diversity
Sustainability
Our achievements
Characterising the BRAF gene
Transforming prostate cancer treatment
Advanced radiotherapy techniques
Identifying a breast cancer gene
Targeting Hsp90
How cells become cancerous
The function of the thymus
Practice changing clinical trials in radiotherapy and imaging
DNA damage and cancer
Identifying cancer predisposition genes
Applying evolutionary biology to cancer
Transforming treatment for the most common type of breast cancer
Developing the Pharmacological Audit Trail
Discovering early chemotherapy drugs
Discovering and developing a leading PI3K inhibitor
Applying genetic principles to treatment of BRCA-mutant cancers
Carcinogens in cigarette smoke
Public engagement and schools outreach
Resources for schools
Public engagement strategy
Public events
Corporate reports and policies
Annual reports
Improving access to clinical trials
Improving drug access
Use of biomarkers in cancer research and treatment
Our policy priorities
Support us
Making a donation
Fundraising
Leave a legacy
Philanthropy
Corporate partnerships
Charity partners
Our appeals
Search newsletter
Making a donation
Why donate to the ICR
How is my money spent
Contact our donations team
Payroll giving
Gift Aid
Fundraising
How to fundraise with us
Sport events and challenges
Fundraising news
Supporter stories
Share your story
Volunteer at our events
Leave a legacy
Create a Will for free
Donate in memory
Information for executors
The National Free Wills Network
Meet our Legacy Marketing Officers
Our appeals
Help us outsmart melanoma
Defeat blood cancer
Help more women survive cancer
Childhood cancers
Combination treatments
Prostate cancer appeal
Monthly gift for cancer patients
Search:
Search
Research and discoveries
Study and careers
Industry partnerships
About us
Support us
See all hubs
Research and discoveries
Find a researcher
ICR divisions
Centres and strategic collaborations
Our research
Our facilities and technology
Research by cancer type
Cancer discovery news
Cancer blogs
See all hubs
Study and careers
PhDs for science graduates
Opportunities for clinicians
Student life and support
Undergraduate Summer Scholarship Scheme
Support moving to the UK
Careers at the ICR
Working life and benefits
See all hubs
Industry partnerships
Partnership opportunities
Consultancy in oncology
Why partner with us
Our therapeutic pipeline
London Cancer Hub
Contact our partner team
See all hubs
About us
Our history
Leadership and governance
Our strategy
ICR and The Royal Marsden
Our achievements
Patient stories
Public engagement and schools outreach
Funding and spending
Corporate reports and policies
ICR news
Contact us
See all hubs
Support us
Making a donation
Fundraising
Leave a legacy
Philanthropy
Corporate partnerships
Charity partners
Our appeals
Search newsletter
See Research and discoveries
Find a researcher
Publications
See Research and discoveries
ICR divisions
Breast Cancer Research
Cancer Biology
Cancer Therapeutics
Cell and Molecular Biology
Clinical Studies
Genetics and Epidemiology
Radiotherapy and Imaging
Structural Biology
See Research and discoveries
Our research
ICR research themes
Our research excellence
Academic excellence
Animal research
Data Science
Drug and therapeutic discovery
See Research and discoveries
Our facilities and technology
Breast Cancer Now Nina Barough Pathology Core Facility
Baculovirus Facility
Light Microscopy Facility
Electron Microscopy Facility
Flow Cytometry Facility
Mechanical Workshop and 3D Printing
Proteomics Core Facility
Scientific Computing Service
Genomics Facility
X-ray Crystallography Facility
Chelsea Biophysics Facility
Correlative Light and Electron Microscopy (CLEM) Lab
Antibody Facility
See Research and discoveries
Research by cancer type
Bladder cancer
Blood cancers
Bone cancer
Bowel cancer
Brain cancer
Breast cancer
Cervical cancer
Childhood cancers
Gastrointestinal cancers
Head and neck cancer
Kidney cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
See Research and discoveries
Cancer discovery news
Media office
See Research and discoveries
Cancer blogs
Research blogs
The Darwin Cancer Blog
See Study and careers
PhDs for science graduates
Our PhD projects
Our PhD application process
PhD FAQs and funding
Contact student admissions
PhDs and training news
See Study and careers
Opportunities for clinicians
MSc in Oncology
PhD and MD(Res) for clinicians
NIHR academic training
Radiotherapy and imaging training courses
Opportunities for postdoctoral clinical fellows
See Study and careers
Student life and support
Tuition fees
Accommodation support
Social life and welfare
Academic and career support
Student resources
Student stories
Alumni stories
See Study and careers
Undergraduate Summer Scholarship Scheme
How to apply
FAQs
Research groups
See Study and careers
Careers at the ICR
Postdocs
Research scientists and scientific support
Group leaders
Clinicians
Professional Service roles
Contact our career faculty
Apprenticeships
See Study and careers
Working life and benefits
Staff benefits
World-leading working facilities
Equality and social groups
Career development
Employee stories
See Industry partnerships
Why partner with us
Our partnership philosophy
The Innovation Gateway
Entrepreneurs-in-residence
Spin-out companies
Enterprise events
Our treatment and technology successes
See Industry partnerships
Contact our partner team
Connections newsletter
See About us
Leadership and governance
Our leadership team
Executive board
Board of trustees
Corporate governance
ICR committees
See About us
Our strategy
Strategic partners
Our values
Equality and diversity
Sustainability
See About us
Our achievements
Characterising the BRAF gene
Transforming prostate cancer treatment
Advanced radiotherapy techniques
Identifying a breast cancer gene
Targeting Hsp90
How cells become cancerous
The function of the thymus
Practice changing clinical trials in radiotherapy and imaging
DNA damage and cancer
Identifying cancer predisposition genes
Applying evolutionary biology to cancer
Transforming treatment for the most common type of breast cancer
Developing the Pharmacological Audit Trail
Discovering early chemotherapy drugs
Discovering and developing a leading PI3K inhibitor
Applying genetic principles to treatment of BRCA-mutant cancers
Carcinogens in cigarette smoke
See About us
Public engagement and schools outreach
Resources for schools
Public engagement strategy
Public events
See About us
Corporate reports and policies
Annual reports
Improving access to clinical trials
Improving drug access
Use of biomarkers in cancer research and treatment
Our policy priorities
See Support us
Making a donation
Why donate to the ICR
How is my money spent
Contact our donations team
Payroll giving
Gift Aid
See Support us
Fundraising
How to fundraise with us
Sport events and challenges
Fundraising news
Supporter stories
Share your story
Volunteer at our events
See Support us
Leave a legacy
Create a Will for free
Donate in memory
Information for executors
The National Free Wills Network
Meet our Legacy Marketing Officers
See Support us
Philanthropy
Our philanthropic activity
See Support us
Corporate partnerships
Corporate partnership highlights
See Support us
Charity partners
Siobhan's Superstar Legacy
See Support us
Our appeals
Help us outsmart melanoma
Defeat blood cancer
Help more women survive cancer
Childhood cancers
Combination treatments
Prostate cancer appeal
Monthly gift for cancer patients
Research and discoveries
Find a researcher
Publications
ICR divisions
Breast Cancer Research
Breast Cancer Clinical Research
Breast Cancer Immunology
Breast Cancer Research Data Science Group
Breast Cancer Systemic Therapy Trials
Breast Epigenetic Plasticity and Evolution
Breast Surgery Outcome Measures
Cancer Dynamics
Cancer Stem Cell
Cell Death and Immunity
Cytoskeleton and Cancer Metastasis
Endocrine Control Mechanisms
Endocrine Therapy Resistance
Functional Genetic Epidemiology
Functional Genomics
Functional Tumour Immunology
Molecular Cell Biology
Molecular Oncology
Target Validation and Genome Stability Group
Precision Oncology
Cancer Biology
Tumour Functional Heterogeneity
Systems and Precision Cancer Medicine Team
Sarcoma Molecular Pathology
Preclinical Modelling of Paediatric Cancer Evolution
Molecular and Systems Oncology Team
Lymphoma biology and imaging
Integrated Pathology
Haemato-Oncology
Glioma
Genomics and Evolutionary Dynamics
Evolutionary Immunogenomics
Computational Pathology and Integrative Genomics
Chronic Lymphoid malignancies: Clinical Trials and Translational Research (El-Sharkawi)
Biology of Childhood Leukaemia
Acute Leukaemia Team
Paediatric Stem Cell Transplant
Cancer Therapeutics
Targeted Protein Degradation
Thoracic Oncology Immunotherapy
Target Evaluation and Molecular Therapeutics
Signal Transduction and Molecular Pharmacology
RNA Biology and Molecular Therapeutics
Myeloma Biology and Therapeutics
Medicinal Chemistry 4 (including Analytical Chemistry)
Medicinal Chemistry 1
Clinical Pharmacology & Trials (including Drug Metabolism and Pharmacokinetics Group)
Chromosomal Translocations and Intracellular Antibody Therapeutics
Clinical Pharmacology Adaptive Therapy
Tumour Microenvironment and Pharmacology
Clinical Pharmacodynamics Biomarker
Cancer Biomarkers
Medicinal Chemistry 3
Hit Discovery and Structural Design
Induced Proximity Therapeutics
Cell and Molecular Biology
Telomere Biology
Structural Biology of Cell Signalling
Signalling and Cancer Metabolism
Short Linear Motif
Post-translational Modifications and Cell Proliferation
Genome Stability and Innate Immunity
Genome Replication
Genome Instability and Cancer
Functional Proteomics
Epigenetics and Genome Stability
Epigenetics and Cancer
Dynamical Cell Systems
PhenoPlot
Development and Cancer
Chromatin Biology
Cell Division
Clinical Studies
Translational Therapeutics
Thoracic Oncology
Sarcoma Clinical Trials and Translational Research
Sarcoma Clinical Trials in Children and Young People
Paediatric & Adolescent Neuro-Oncology and Drug Development (Carceller)
Melanoma and Kidney Cancer Group
The Adult Drug Development Unit at the ICR and the RM
Our research at the DDU
Health Informatics
ICR-CTSU Radiotherapy, Urology and Head and Neck Cancers Trials
ICR-CTSU Integrative Genomic Analysis in Clinical Trials
ICR-CTSU Early Phase and Adaptive Trials
The OPTIMISE-AR project
The DEFINE study SPIRIT and CONSORT extensions
ICR-CTSU Breast and Rare Cancers Trials
Gynaecological Oncology Surgery
Gynaecological Cancers (Systemic Therapy and Clinical Trials)
Developmental Oncology
Cancer Biomarkers
Prostate Cancer Targeted Therapy Group
Paediatric Solid Tumour Biology and Therapeutics
Genetics and Epidemiology
Translational Genetics
Oncogenetics
IMPACT
PMPRC
PRACTICAL
UK Genetic Prostate Cancer Study
The PROFILE Study
GENPROS
GENPET
BARCODE 1
BARCODE 2
PRODICT Study
Myeloma Molecular Therapy
Integrative Cancer Epidemiology
Clinical Cancer Epidemiology
Cancer Genomics
PICS Database
SNPLINK Database
National Study of Colorectal Cancer Genetics (NSCCG)
FCLL study
National Brain Tumour (NBT) study
TRANSORCE study
Radiotherapy and Imaging
Uro-oncology clinical trials
Ultrasound and Optical Imaging
Translational Therapeutic Radiography
Translational Sarcoma, Melanoma and Rare Tumour Surgery
Translational Immunotherapy
Translational Breast Radiobiology
Targeted Therapy Group
Stereotactic and Precision Radiotherapy
Sarcoma and Melanoma Surgery
Radiation-enhanced Immunotherapy
Radiotherapy Physics Modelling
Radioisotope Physics
Quantitative Biomedical Imaging
Prostate and Bladder Cancer Research
Pre-Clinical MRI
Preclinical Molecular Imaging
Magnetic Resonance Imaging in Radiotherapy
Oncogenetics
Clinical Academic Radiotherapy Team (Huddart)
Functional Imaging Group
Imaging for Radiotherapy Adaptation Team
Breast Cancer Radiotherapy
Magnetic Resonance
Therapeutic Ultrasound
Multimodality Molecular Imaging
Gastrointestinal Clinical Oncology
Computational Imaging
Evolution and Translational Genomics
Experimental and Translational Theranostic
Structural Biology
Structural Biology of DNA Repair Complexes
Structural Biology of Cell Signalling
Molecular Mechanisms of Cell Cycle Regulation
Mechanisms and Regulation of pre-mRNA Splicing
Macromolecular Structural Biology Team
Centres and strategic collaborations
Our research
ICR research themes
Chemical probes
Immunotherapy
Genomics
Artificial intelligence
Clinical trials
Cancer evolution
Biomarkers
Our discovery of the BRCA2 cancer gene
Our research excellence
Academic excellence
Animal research
Data Science
Drug and therapeutic discovery
Our facilities and technology
Breast Cancer Now Nina Barough Pathology Core Facility
Baculovirus Facility
Light Microscopy Facility
Electron Microscopy Facility
Flow Cytometry Facility
Mechanical Workshop and 3D Printing
Proteomics Core Facility
Scientific Computing Service
Genomics Facility
X-ray Crystallography Facility
Chelsea Biophysics Facility
Correlative Light and Electron Microscopy (CLEM) Lab
Antibody Facility
Research by cancer type
Bladder cancer
Blood cancers
Bone cancer
Bowel cancer
Brain cancer
Breast cancer
Cervical cancer
Childhood cancers
Gastrointestinal cancers
Head and neck cancer
Kidney cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
Cancer discovery news
Media office
Cancer blogs
Research blogs
The Darwin Cancer Blog
Study and careers
PhDs for science graduates
Our PhD projects
PhD project archive
Our PhD application process
PhD FAQs and funding
Contact student admissions
PhDs and training news
Opportunities for clinicians
MSc in Oncology
Course essentials
PhD and MD(Res) for clinicians
Course essentials
NIHR academic training
Radiotherapy and imaging training courses
Radioactive waste advisers training course
Nuclear medicine and PET imaging course
Magnetic resonance imaging (MRI) and spectroscopy course
Physics of medical imaging courses
Image Guided and Adaptive Radiotherapy in Clinical Practice: Including SABR Topics
Radiation Protection Training Course
Practical and Theoretical Radiotherapy Physics Courses
Diagnostic radiology & CT course
Ultrasound imaging course
Image theory, perception and processing course
Magnetic Resonance Image Guided Radiotherapy (MRIgRT)
Opportunities for postdoctoral clinical fellows
Student life and support
Tuition fees
Accommodation support
Social life and welfare
Academic and career support
Alumni, careers and destinations
Student resources
Library and E-learning
Student stories
Alumni stories
Undergraduate Summer Scholarship Scheme
How to apply
FAQs
Research groups
Support moving to the UK
Careers at the ICR
Postdocs
Research scientists and scientific support
Group leaders
Clinicians
Professional Service roles
Contact our career faculty
Apprenticeships
Scientific Apprenticeship Conference
Working life and benefits
Staff benefits
World-leading working facilities
Equality and social groups
Career development
Employee stories
Industry partnerships
Partnership opportunities
Consultancy in oncology
Why partner with us
Our partnership philosophy
The Innovation Gateway
Entrepreneurs-in-residence
Spin-out companies
Enterprise events
Our treatment and technology successes
Our therapeutic pipeline
London Cancer Hub
Contact our partner team
Connections newsletter
About us
Our history
Leadership and governance
Our leadership team
Executive board
Board of trustees
Corporate governance
ICR committees
Our strategy
Strategic partners
Our values
Equality and diversity
Sustainability
Responsibilities
ICR and The Royal Marsden
Our achievements
Characterising the BRAF gene
Transforming prostate cancer treatment
Advanced radiotherapy techniques
Identifying a breast cancer gene
Targeting Hsp90
How cells become cancerous
The function of the thymus
Practice changing clinical trials in radiotherapy and imaging
DNA damage and cancer
Identifying cancer predisposition genes
Applying evolutionary biology to cancer
Transforming treatment for the most common type of breast cancer
Developing the Pharmacological Audit Trail
Discovering early chemotherapy drugs
Discovering and developing a leading PI3K inhibitor
Applying genetic principles to treatment of BRCA-mutant cancers
Carcinogens in cigarette smoke
Patient stories
Public engagement and schools outreach
Resources for schools
Public engagement strategy
Public events
Funding and spending
Corporate reports and policies
Annual reports
Improving access to clinical trials
Improving drug access
Use of biomarkers in cancer research and treatment
Our policy priorities
ICR news
Contact us
Support us
Making a donation
Why donate to the ICR
How is my money spent
Contact our donations team
Payroll giving
Gift Aid
Fundraising
How to fundraise with us
How to fundraise with us (Thank you)
Sport events and challenges
London Marathon 2026
Fundraising news
Supporter stories
Share your story
Volunteer at our events
Leave a legacy
Create a Will for free
Legacy support FAQs
Solicitor FAQs
Will for free programme members
Donate in memory
Information for executors
The National Free Wills Network
Meet our Legacy Marketing Officers
Philanthropy
Our philanthropic activity
Centre for cancer discovery appeal
Carols from Chelsea
Cancer's last note
Discovery Verses
Pipette painting marks pioneering cancer research
Finished symphony marks a new era of cancer drug discovery
Lab coat
Corporate partnerships
Corporate partnership highlights
Charity partners
Siobhan's Superstar Legacy
Our appeals
Help us outsmart melanoma
Defeat blood cancer
Help more women survive cancer
Childhood cancers
Combination treatments
Prostate cancer appeal
Monthly gift for cancer patients
Search newsletter
Contact us
Register my fundraising event
Subscribe to Search Newsletter
Subscribe to Phd opportunities
Contact the Development office
Order a legacy guide
Complete a gift aid declaration
Request a Breakthrough Generations pack
Contact the Registry team
member-gate
